|
Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial
RECRUITINGN/ASponsored by Anhui Medical University
Actively Recruiting
PhaseN/A
SponsorAnhui Medical University
Started2026-09-01
Est. completion2027-09-01
Eligibility
Age45 Years – 84 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07827196
Summary
To investigate the treatment effect of Transcranial random noise (tRNS) on Alzheimer patients, and the underlying neural mechanism by EEG.
Eligibility
Age: 45 Years – 84 YearsHealthy volunteers accepted
Inclusion Criteria: * Subject diagnosed with early Alzheimer's disease or related diseases according to NINCDS-ACDRADA criteria. * Subjects must have a MMSE score between 10 and 27,indicating mild cognitive impairment or dementia * CDR score ≤ 2 * Subject under treatment by IAChE for at least 3 months. * psychotropic treatments are tolerated if they were administered and unchanged for at least 3 months Exclusion Criteria: * NPI ≥ 4 * CDR \> 2 * Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder). * History of head injury,stroke,or other neurologic disease. * Organic brain defects on T1 or T2 images. * History of seizures or unexplained loss of consciousness. * Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator. * Family history of medication refractory epilepsy. * History of substance abuse within the last 6 months.
Conditions5
Alzheimer DiseaseAlzheimer's DiseaseBPSD (Behavioral and Psychological Symptoms of Dementia)ElectroencephalographyTranscranial Random Noise Stimulation (tRNS)
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorAnhui Medical University
Started2026-09-01
Est. completion2027-09-01
Eligibility
Age45 Years – 84 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07827196